Xinyan Wu1,2,3, Muhammad Saddiq Zahari1,2, Santosh Renuse1,2,4, Nandini A Sahasrabuddhe1,2,4,5, Raghothama Chaerkady1,2, Mi-Sik Kim1,2, Mary Jo Fackler6, Martha Stampfer7, Edward Gabrielson6,8, Saraswati Sukumar6, Akhilesh Pandey1,2,4,3. 1. 1Department of Biological Chemistry, Johns Hopkins University, Baltimore, MD USA. 2. 2McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, MD USA. 3. 8Johns Hopkins University, 733 N. Broadway, Baltimore, MD 21205 USA. 4. 3Institute of Bioinformatics, International Technology Park, Bangalore, 560066 India. 5. 4Manipal Academy of Higher Education, Manipal, Karnataka 576104 India. 6. 5Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205 USA. 7. 7Division of Biological Systems and Engineering, Lawrence Berkeley National Laboratory, Berkeley, CA USA. 8. 6Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205 USA.
Abstract
[This corrects the article DOI: 10.1186/s12014-018-9197-x.].
[This corrects the article DOI: 10.1186/s12014-018-9197-x.].
Correction to: Clin Proteom (2018) 15:21 10.1186/s12014-018-9197-x
Unfortunately, after publication of this article [1], errors were noticed in Figs. 3 and 4. The “T” in the word “pTyr” was missing in Fig. 3. The word “change” was missing after the word “Fold” in the label of y axis in Fig. 4a. The “e” in the word “Co-culture” was missing in Fig. 4a. The correct figures are presented in this correction. The original article has also been updated.
Fig. 3
Phosphotyrosine profiling of cancer epithelial cells and interacting CAFs. a, b Density scatter plot of log2-transformed phosphopeptide intensity ratios (82T-co-cultured vs. 82T (A) and MDA-MB-231-co-cultured vs. MDA-MB-231) from two SILAC biological experiments. c Pie chart showing the composition of pTyr and pSer/Thr peptides identified in the phosphoproteomic analysis. d Venn diagram showing overlap of phosphopeptides identified in MDA-MB-231 and 82T cells. e, f Gene ontology analysis of phosphoproteins in cancer epithelium and CAFs. e Cellular component; f molecular functions
Fig. 4
Reciprocal activation of receptor tyrosine kinases induced by the crosstalk. a Distribution of phosphorylation ratio of pY peptides. Blue dots: log2-transformed ratio of MDA-MB-231-co-cultured versus MDA-MB-231; red dots: log2-transformed ratio of 82T-co-cultured versus 82T. b, c Representative spectrum of FGFR1 (b) and EGFR (c) identified in cancer epithelium and CAFs. Top panels: MS spectra and bottom panels: MS/MS spectra for phosphotyrosine-containing peptides identified for FGFR1 and EGFR
Phosphotyrosine profiling of cancer epithelial cells and interacting CAFs. a, b Density scatter plot of log2-transformed phosphopeptide intensity ratios (82T-co-cultured vs. 82T (A) and MDA-MB-231-co-cultured vs. MDA-MB-231) from two SILAC biological experiments. c Pie chart showing the composition of pTyr and pSer/Thr peptides identified in the phosphoproteomic analysis. d Venn diagram showing overlap of phosphopeptides identified in MDA-MB-231 and 82T cells. e, f Gene ontology analysis of phosphoproteins in cancer epithelium and CAFs. e Cellular component; f molecular functionsReciprocal activation of receptor tyrosine kinases induced by the crosstalk. a Distribution of phosphorylation ratio of pY peptides. Blue dots: log2-transformed ratio of MDA-MB-231-co-cultured versus MDA-MB-231; red dots: log2-transformed ratio of 82T-co-cultured versus 82T. b, c Representative spectrum of FGFR1 (b) and EGFR (c) identified in cancer epithelium and CAFs. Top panels: MS spectra and bottom panels: MS/MS spectra for phosphotyrosine-containing peptides identified for FGFR1 and EGFR